Emotional and Affective Responses to Music Inspired by Permafrost Thaw in Nunavik
NCT07915089, Not applicable, Not yet recruiting, Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Emotional and Affective Responses to Music Inspired by Permafrost Thaw in Nunavik | ClinicalTrials.gov |
| NCT number | NCT07915089 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal | ClinicalTrials.gov |
| Conditions | Emotion, Affective Response, Physiological Responses | ClinicalTrials.gov |
| Interventions | Viewing Four Audiovisual Artworks Inspired by Environmental Changes in Nunavik | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Affect Grid Valence Score Following Each Audiovisual Artwork | Immediately before and after each 3-minute-50-second artwork during one approximately 60-minute laboratory session. | Emotional valence is assessed using the horizontal coordinate of the Affect Grid, ranging from 1 (unpleasant) to 9 (pleasant). For each artwork, change is calculated as the score immediately after viewing minus the score immediately before viewing. Positive changes indicate greater pleasantness. Responses are compared across the four artworks within participants. | ClinicalTrials.gov |
| Primary | Change in Affect Grid Arousal Score Following Each Audiovisual Artwork | Immediately before and after each 3-minute-50-second artwork during one approximately 60-minute laboratory session. | Subjective arousal is assessed using the vertical coordinate of the Affect Grid, ranging from 1 (low arousal) to 9 (high arousal). For each artwork, change is calculated as the score immediately after viewing minus the score immediately before viewing. Positive changes indicate greater subjective activation. Responses are compared across the four artworks within participants. | ClinicalTrials.gov |
| Primary | Electrodermal Responses During Audiovisual Artwork Viewing | During the approximately one-minute rest before each artwork and throughout each 3-minute-50-second presentation, within one approximately 60-minute session. | Electrodermal activity is recorded continuously using the Shimmer3 GSR+ device. Tonic skin conductance level and phasic skin conductance responses characterise physiological activation during each artwork. Recordings are evaluated relative to the approximately one-minute resting period preceding each artwork and compared across the four artworks within participants. Skin conductance is expressed in microsiemens; higher activity does not identify whether an emotion is positive or negative. | ClinicalTrials.gov |
| Primary | Heart Rate Responses During Audiovisual Artwork Viewing | During the approximately one-minute rest before each artwork and throughout each 3-minute-50-second presentation, within one approximately 60-minute session. | Heart rate is estimated from the photoplethysmographic pulse signal recorded using the Shimmer3 GSR+ device and expressed in beats per minute. Responses during each artwork are evaluated relative to the preceding approximately one-minute resting period and compared across the four artworks within participants. | ClinicalTrials.gov |
| Secondary | Change in Global Affective Polarity Following Each Audiovisual Artwork | Immediately before and after each 3-minute-50-second artwork during one approximately 60-minute laboratory session. | Global Affective Polarity (GAP) is a study-developed exploratory composite based on six items rated from 0 to 10. GAP-P is the mean of pleasantness, joy and appeasement; GAP-N is the mean of unpleasantness, sadness and melancholy. Global GAP equals GAP-P minus GAP-N and ranges from -10 to +10. Higher scores indicate predominance of positive affective components. Component scores each range from 0 to 10. Changes are calculated separately for each artwork as post-viewing minus pre-viewing scores. | ClinicalTrials.gov |
| Secondary | Change in Nature Connection Index Score | At inclusion before the laboratory visit and immediately after viewing all four artworks during the approximately 60-minute laboratory session. | Nature connectedness is assessed using the six-item Nature Connection Index. Responses are recorded on seven-point agreement scales and coded so that higher values indicate stronger connectedness. Under the study protocol, the mean item score is transformed to a 0-100 index using \[(mean score - 1)/6\] × 100. Higher scores indicate greater nature connectedness. Change is calculated as the score after viewing all four artworks minus the score collected at inclusion. | ClinicalTrials.gov |
| Secondary | Change in Hogg Eco-Anxiety Scale Score | At inclusion before the laboratory visit and immediately after viewing all four artworks during the approximately 60-minute laboratory session. | Eco-anxiety is assessed using the 13-item Hogg Eco-Anxiety Scale (HEAS-13). Items are rated from 0 to 3 and summed to produce a total score ranging from 0 to 39. Higher scores indicate more frequent eco-anxiety-related responses. Change is calculated as the score after viewing all four artworks minus the score collected at inclusion. This exploratory assessment does not imply that the artworks constitute a treatment for eco-anxiety. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)